Chris Glancy is an intellectual property lawyer with a broad range of experience. He has litigated and tried cases involving patents, trademarks, copyrights, trade secrets, and false advertising, as well as contract disputes.
As a member of our global Data, Privacy and Cyber Security Group, Chris counsels clients on U.S. data privacy law. He also keeps abreast of the latest developments in IP law relating to the internet and e-commerce and regularly counsels clients on these issues.
He has represented clients in a wide array of industries, including the pharmaceutical, music, television, sports, ecommerce, publishing, finance, automotive, jewelry, and telecommunications industries.
Representation of pharma company UCB in a patent infringement action brought by Apotex in the Southern District of Florida. In this post-Therasense case, the court ruled, after a three-day bench trial on UCB's equitable defenses, that the patent was unenforceable due to multiple acts of inequitable conduct. The Federal Circuit affirmed. The district court also ruled that the patent was invalid as indefinite, and that Apotex's claims were otherwise barred by judicial estoppel, prosecution disclaimer, and laches.
Representation of credit reporting agency Experian in a trademark infringement, false advertising and antitrust litigation brought by Fair Isaac in the District of Minnesota. The court granted our client's motion for summary judgment on Fair Isaac's false advertising and antitrust claims. A jury trial on the trademark claims followed, and we prevailed. The jury found that Fair Isaac's alleged trademark in its scoring scale "300-850" did not acquire secondary meaning and that Fair Isaac committed fraud on the Trademark Office in procuring its registration. Separately, the court ruled that Fair Isaac had failed to prove its keyword advertising trademark claims. The Eighth Circuit affirmed.
Representation of Google and other technology companies in three amicus briefs filed in the Federal Circuit in the 'Apple v. Samsung' patent litigation.
Representation of Pfizer in breach of contract litigation in New York state court.
Advising world-leading online retailer on various trademark and keyword advertising matters.
Representation of Zales in a false advertising litigation brought by rival Sterling Jewelers, the owner of Kaye Jewelers and Jared. We defeated Sterling's motion for preliminary injunction, which had the potential to seriously disrupt Zales' entire advertising campaign at the height of the holiday season. The case later settled on terms favorable to our client.
Advising pharma clients Pfizer, Novo Nordisk and Lundbeck on trademark and copyright matters.
Representation of Verizon Wireless in false advertising disputes against AT&T Mobility in federal court. The case concerned both parties' advertising claims regarding network coverage, quality and reliability.
Representation of ESPN in a trademark infringement action brought by Playmakers LLC, a sports agency, in federal court in Washington. The plaintiff claimed that the title of our client's TV series, Playmakers, infringed its mark. The district court granted our motion for summary judgment of noninfringement, which was affirmed by the Ninth Circuit.
"White & Case Digital Health Conference", 2014:
"'Viacom v. YouTube': The Second Circuit construes the DMCA safe-harbor for user uploaded content", 2012: Law Seminars Int'l
A Survey of 2010 Dilution Cases: Comparison of the Standard Used to Evaluate the Similarity of the Marks in Dilution by Blurring Decisions, Inside the Minds: Recent Trends in Trademark Protection, Aspatore, 2011 ed., (co-author)
The Trademark Dilution Revision Act of 2006 Clarification and Expansion of the Fair Use Exception, MLRC Media Law Letter, October 31, 2006, (co-author)
Searching for Clarity: Trademark Disputes Over Keyword Advertising Have Returned Confusing Results, IP Law & Business, January 2006
End of the Domain Goldrush? An Overview of the Anticybersquatting Consumer Protection Act, Internet Law & Business, January 2000